Intraumbilical Misoprostol in Retained Placenta

• Status: Completed
• Trial end date: 2012-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

Administration of intraumbilical misoprostol to women with retained placenta despite active management of third stage of labour reduces the need for manual removal of placenta and the amount of blood loss vaginally.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hawler Medical University
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• women having singleton pregnancy

• 28 weeks of gestation or more delivered vaginally

• prolongation of the third stage of labour (more than 30 min) following active management of third stage of labour

Exclusion Criteria:

• Who refused to participate in the trial

• Multiple pregnancies

• Previous Caesarean Section

• Haemodynamically unstable

• Severe anaemia (haemoglobin less than 8gm/dl)

• Chorioamnionitis